Literature DB >> 14691458

The zinc-finger transcription factor GLI2 antagonizes contact inhibition and differentiation of human epidermal cells.

Gerhard Regl1, Maria Kasper, Harald Schnidar, Thomas Eichberger, Graham W Neill, Mohammed S Ikram, Anthony G Quinn, Mike P Philpott, Anna-Maria Frischauf, Fritz Aberger.   

Abstract

In stratified epidermis, activation of the Hh/Gli signal transduction pathway has been implicated in the control of cell proliferation and tumorigenesis. The zinc-finger transcription factor Gli2 has been identified as critical mediator of the Hh signal at the distal end of the pathway, but the molecular mechanisms by which Gli2 regulates cell proliferation or induces epidermal malignancies such as basal cell carcinoma are still unclear. Here, we provide evidence for a role of human GLI2 in antagonizing contact inhibition and epidermal differentiation. We show by gene expression profiling that activation of the GLI2 oncogene in human keratinocytes activates the transcription of a number of genes involved in cell cycle progression such as E2F1, CCND1, CDC2 and CDC45L, while it represses genes associated with epidermal differentiation. Analysis of the proliferative effect of GLI2 revealed that GLI2 is able to induce G1-S phase progression in contact-inhibited keratinocytes. Detailed time-course experiments identified E2F1 as early transcriptional target of GLI2. Further, we show that GLI2 expression in human keratinocytes results in a marked downregulation of epidermal differentiation markers. The data suggest a role for GLI2 in Hh-induced epidermal neoplasia by opposing epithelial cell cycle arrest signals and epidermal differentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14691458     DOI: 10.1038/sj.onc.1207240

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  The vitamin D receptor: a tumor suppressor in skin.

Authors:  Daniel David Bikle
Journal:  Discov Med       Date:  2011-01       Impact factor: 2.970

2.  Dynamic Remodeling of Membrane Composition Drives Cell Cycle through Primary Cilia Excision.

Authors:  Siew Cheng Phua; Shuhei Chiba; Masako Suzuki; Emily Su; Elle C Roberson; Ganesh V Pusapati; Stéphane Schurmans; Mitsutoshi Setou; Rajat Rohatgi; Jeremy F Reiter; Koji Ikegami; Takanari Inoue
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

3.  Hedgehog signaling promotes medulloblastoma survival via Bc/II.

Authors:  Eli E Bar; Aneeka Chaudhry; Mohamed H Farah; Charles G Eberhart
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

4.  Study of the differentially expressed genes in pleomorphic adenoma using cDNA microarrays.

Authors:  Meng Song; Cuicui Xiao; Tingle Wang; Qingguo Pei; Shiwei Wang; Liqun Xu; Wantao Chen
Journal:  Pathol Oncol Res       Date:  2011-05-09       Impact factor: 3.201

Review 5.  Protective role of vitamin D signaling in skin cancer formation.

Authors:  Daniel D Bikle; Hashem Elalieh; Joellen Welsh; Dennis Oh; James Cleaver; Arnaud Teichert
Journal:  J Steroid Biochem Mol Biol       Date:  2012-10-08       Impact factor: 4.292

Review 6.  Protective actions of vitamin D in UVB induced skin cancer.

Authors:  Daniel D Bikle
Journal:  Photochem Photobiol Sci       Date:  2012-12       Impact factor: 3.982

7.  Hedgehog signaling is involved in differentiation of normal colonic tissue rather than in tumor proliferation.

Authors:  Beate Alinger; Tobias Kiesslich; Christian Datz; Fritz Aberger; Felix Strasser; Frieder Berr; Otto Dietze; Klaus Kaserer; Cornelia Hauser-Kronberger
Journal:  Virchows Arch       Date:  2009-03-12       Impact factor: 4.064

8.  Reprogramming of keratin biosynthesis by sulforaphane restores skin integrity in epidermolysis bullosa simplex.

Authors:  Michelle L Kerns; Daryle DePianto; Albena T Dinkova-Kostova; Paul Talalay; Pierre A Coulombe
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-27       Impact factor: 11.205

9.  Stromal control of oncogenic traits expressed in response to the overexpression of GLI2, a pleiotropic oncogene.

Authors:  A M Snijders; B Huey; S T Connelly; R Roy; R C K Jordan; B L Schmidt; D G Albertson
Journal:  Oncogene       Date:  2008-11-17       Impact factor: 9.867

10.  Smoothened as a new therapeutic target for human osteosarcoma.

Authors:  Masataka Hirotsu; Takao Setoguchi; Hiromi Sasaki; Yukihiro Matsunoshita; Hui Gao; Hiroko Nagao; Osamu Kunigou; Setsuro Komiya
Journal:  Mol Cancer       Date:  2010-01-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.